CDC42EP3 promotes glioma progression via regulation of CCND1
Open Access
- 1 April 2022
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (4) , 1-12
Abstract
Gliomas are the most common brain malignancies characterized by high degree of aggressiveness and high mortality. However, the underlying mechanism of glioma progression remains unclear. Here, we probed the role of CDC42EP3 (CDC42 effector protein 3) played in glioma development and its potential downstream mechanism. The expression of CDC42EP3 in tumor and normal brain tissues were examined through immunohistochemistry and we found the likelihood of CDC42EP3 overexpression was positively correlated with pathological grading. Patients with higher expression of CDC42EP3 were more likely to suffer from recurrence as well. Through constructing CDC42EP3-knockdown cell models, we discovered that silencing CDC42EP3 significantly restricted cell proliferation and migration but facilitated cell apoptosis in vitro. Inhibition on tumor growth mediated by CDC42EP3 depletion was further verified in vivo. Regarding downstream target of CDC42EP3, we found that it may positively regulate the expression of CCND1 through c-Myc-mediated transcription. Furthermore, our findings affirmed that effects of CDC42EP3 overexpression on cell proliferation, migration and apoptosis could be confined by depleting CCND1. In a word, this study reported the tumor-promoting role of CDC42EP3 in glioma progression which probably functioned through targeting CCND1.Keywords
This publication has 30 references indexed in Scilit:
- Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoterJournal of Experimental & Clinical Cancer Research, 2017
- Letter: Is Serum Glial Fibrillary Acidic Protein a Comprehensive Marker for High-Grade Glioma?Operative Neurosurgery, 2017
- Homeobox Transcription Factor NKX2-1 PromotesCyclin D1Transcription in Lung AdenocarcinomasMolecular Cancer Research, 2017
- Inflammatory landscape of human brain tumors reveals an NFκB dependent cytokine pathway associated with mesenchymal glioblastomaCancer Letters, 2017
- Cyclin D1, cancer progression, and opportunities in cancer treatmentJournal of Molecular Medicine, 2016
- Cdc42 regulates Cdc42EP3 function in cancer-associated fibroblastsSmall GTPases, 2016
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- GliomaNature Reviews Disease Primers, 2015
- NF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageExpert Review of Neurotherapeutics, 2014
- Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomasJournal of Neuro-Oncology, 2012